Lorinda Burgess - Jul 19, 2023 Form 4 Insider Report for ANGIODYNAMICS INC (ANGO)

Role
Director
Signature
/s/ Stephen A. Trowbridge, Attorney in Fact
Stock symbol
ANGO
Transactions as of
Jul 19, 2023
Transactions value $
$0
Form type
4
Date filed
7/21/2023, 08:06 PM
Previous filing
Apr 27, 2023
Next filing
May 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANGO Common Stock Award $0 +17K $0.00 17K Jul 19, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The acquisition of 17,041 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 17,041 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant.